Reckitt Benckiser Group plc (FRA:3RB)

Market Cap	41.02B
Revenue (ttm)	17.13B
Net Income (ttm)	1.72B
Shares Out	n/a
EPS (ttm)	2.46
PE Ratio	23.79
Forward PE	14.88
Dividend	2.36 (4.05%)
Ex-Dividend Date	Apr 10, 2025

Volume	n/a
Average Volume	205
Open	59.04
Previous Close	59.18
Day's Range	58.28 - 59.04
52-Week Range	47.82 - 64.54
Beta	n/a
RSI	41.18
Earnings Date	Jul 24, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol bran...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1819
• Employees: 37,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 3RB

Financial Performance

In 2024, Reckitt Benckiser Group's revenue was 14.17 billion, a decrease of -3.00% compared to the previous year's 14.61 billion. Earnings were 1.43 billion, a decrease of -13.21%.

Financial numbers in GBP